| Literature DB >> 27899093 |
Sharmila Suwal1, Dinesh Bhandari2,3, Pratigya Thapa1, Mohan Krishna Shrestha4, Jyoti Amatya1.
Abstract
BACKGROUND: Corneal ulcer, a major cause of monocular blindness in developing countries has consistently been listed as the major cause of blindness and visual disability in many of the developing nations in Asia, Africa and the Middle East, ranking second only to cataract. This study was carried out to determine the microbiological profile of corneal ulcer cases diagnosed among patients visiting Tilganga Institute of Ophthalmology (TIO), Nepal.Entities:
Keywords: Corneal ulcer; Microbiological profile; Nepal
Mesh:
Substances:
Year: 2016 PMID: 27899093 PMCID: PMC5129215 DOI: 10.1186/s12886-016-0388-9
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Etiology of Corneal ulcers
| Etiologies | Frequency (%) | |
|---|---|---|
| Bacterial corneal ulcer ( |
| 3 (6.7) |
|
| 3 (6.7) | |
|
| 1 (2.2) | |
|
| 1 (2.2) | |
|
| 14 (31.1) | |
| Viridians group of streptococci | 3 (6.7) | |
| Fungal corneal ulcer ( |
| 5 (11.1) |
|
| 1 (2.2) | |
|
| 2 (4.4) | |
|
| 1 (2.2) | |
|
| 6 (13.4) | |
| Unidentified dematiaceous fungi | 5 (11.1) | |
| Total | 45 (100) |
Demographic factors and clinical presentations of corneal ulcers
| Demographic variables | Particulars ( | Corneal ulcer positive cases, |
|---|---|---|
| Gender | Male ( | 19 (42.2%) |
| Female ( | 26 (57.8%) | |
| Age in years | <10 years ( | 0 |
| 11–20 years ( | 1 (2.2%) | |
| 21–30 years ( | 4 (8.9%) | |
| 31–40 years ( | 8 (17.8%) | |
| 41–50 years ( | 3 (6.7%) | |
| 51–60 years (n = 28) | 18 (40%) | |
| 61–70 years ( | 7 (15.6%) | |
| 71–80 years ( | 2 (4.4%) | |
| >80 years ( | 2 (4.4%) | |
| Occupation | Agriculture ( | 26 (57.8%) |
| Others ( | 19 (42.2%) | |
| Education | Illiterate ( | 33 (73.3%) |
| Literate ( | 12 (26.7%) | |
| Trauma | Yes ( | 13 (28.9%) |
| No ( | 32 (71.1%) |
aThe percentage has been derived, taking the total positive cases as denominator (N = 45)
Antibiotic susceptibility pattern of bacterial isolates
| Organisms | Antibiotics Used | Susceptibility Patterns | Resistant | |
|---|---|---|---|---|
| Susceptible | Intermediate | |||
|
| Azithromycin | 14 | 0 | 0 |
| Ceftazidime | 14 | 0 | 0 | |
| Chloramphenicol | 14 | 0 | 0 | |
| Ciprofloxacin | 14 | 0 | 0 | |
| Moxifloxacin | 14 | 0 | 0 | |
| Ofloxacin | 14 | 0 | 0 | |
| Viridians group of streptococci ( | Azithromycin | 3 | 0 | 0 |
| Ceftazidime | 3 | 0 | 0 | |
| Chloramphenicol | 3 | 0 | 0 | |
| Ciprofloxacin | 3 | 0 | 0 | |
| Moxifloxacin | 3 | 0 | 0 | |
| Ofloxacin | 3 | 0 | 0 | |
|
| Amikacin | 1 | 0 | 0 |
| Ceftazidime | 1 | 0 | 0 | |
| Chloramphenicol | 0 | 0 | 1 | |
| Ciprofloxacin | 0 | 1 | 0 | |
| Moxifloxacin | 1 | 0 | 0 | |
| Ofloxacin | 1 | 0 | 0 | |
|
| Amikacin | 3 | 0 | 0 |
| Azithromycin | 1 | 0 | 2 | |
| Chloramphenicol | 1 | 0 | 2 | |
| Ciprofloxacin | 3 | 0 | 0 | |
| Moxifloxacin | 3 | 0 | 0 | |
| Ofloxacin | 3 | 0 | 0 | |
|
| Amikacin | 3 | 0 | 0 |
| Azithromycin | 1 | 0 | 2 | |
| Chloramphenicol | 3 | 0 | 0 | |
| Ciprofloxacin | 1 | 0 | 2 | |
| Moxifloxacin | 3 | 0 | 0 | |
| Ofloxacin | 1 | 0 | 2 | |
|
| Amikacin | 1 | 0 | 0 |
| Ceftazidime | 0 | 0 | 1 | |
| Chloramphenicol | 0 | 0 | 1 | |
| Ciprofloxacin | 1 | 0 | 0 | |
| Moxifloxacin | 1 | 0 | 0 | |
| Ofloxacin | 1 | 0 | 0 | |